Editorial : Molecular targets for anticancer drug discovery and development
| dc.contributor.author | Ntwasa, Monde | |
| dc.contributor.author | Dlamini, Zodwa | |
| dc.contributor.email | zodwa.dlamini@up.ac.za | en_US |
| dc.date.accessioned | 2024-12-04T12:30:44Z | |
| dc.date.available | 2024-12-04T12:30:44Z | |
| dc.date.issued | 2024-04 | |
| dc.description.abstract | No abstract available. | en_US |
| dc.description.department | Medical Oncology | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.sponsorship | The South African Medical Research Council (SAMRC), and the National Research Foundation (NRF). | en_US |
| dc.description.uri | https://www.frontiersin.org/journals/genetics | en_US |
| dc.identifier.citation | Ntwasa, M. & Dlamini, Z. (2024), Editorial: Molecular targets for anticancer drug discovery and development. Frontiers in Genetics 15:1374867. doi: 10.3389/fgene.2024.1374867. | en_US |
| dc.identifier.issn | 1664-8021 (online) | |
| dc.identifier.other | 10.3389/fgene.2024.1374867 | |
| dc.identifier.uri | http://hdl.handle.net/2263/99767 | |
| dc.language.iso | en | en_US |
| dc.publisher | Frontiers Media | en_US |
| dc.rights | © 2024 Ntwasa and Dlamini. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY). | en_US |
| dc.subject | Small molecule anticancer drugs | en_US |
| dc.subject | Molecularly targeted therapies | en_US |
| dc.subject | Pharmacogenetics | en_US |
| dc.subject | Model organisms (Drosophila) | en_US |
| dc.subject | Drug repurposing | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.subject | Editorial | en_US |
| dc.title | Editorial : Molecular targets for anticancer drug discovery and development | en_US |
| dc.type | Article | en_US |